scholarly article | Q13442814 |
P50 | author | Tone F. Bathen | Q61104171 |
May-Britt Tessem | Q64706553 | ||
Finn Drabløs | Q43415197 | ||
P2093 | author name string | Alan J Wright | |
Trond Viset | |||
Ailin Falkmo Hansen | |||
Anna M Bofin | |||
Elin Richardsen | |||
Elise Sandsmark | |||
Helena Bertilsson | |||
Kirsten M Selnæs | |||
Morten B Rye | |||
P2860 | cites work | The clinical relevance of the metabolism of prostate cancer; zinc and tumor suppression: connecting the dots | Q21093286 |
Wnt signaling pathways in urological cancers: past decades and still growing | Q21245761 | ||
Hallmarks of Cancer: The Next Generation | Q22252312 | ||
A noncanonical Frizzled2 pathway regulates epithelial-mesenchymal transition and metastasis | Q24307454 | ||
Wnt-5a inhibits the canonical Wnt pathway by promoting GSK-3-independent beta-catenin degradation | Q24319714 | ||
Constitutive transcriptional activation by a beta-catenin-Tcf complex in APC-/- colon carcinoma | Q24336272 | ||
Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles | Q24536351 | ||
The basics of epithelial-mesenchymal transition | Q24652992 | ||
Wnt/β-catenin signalling in prostate cancer | Q28269116 | ||
Elevated level of Wnt5a protein in localized prostate cancer tissue is associated with better outcome | Q28477590 | ||
Discovery and validation of a prostate cancer genomic classifier that predicts early metastasis following radical prostatectomy | Q28534277 | ||
Emphasizing the role of Wnt5a protein expression to predict favorable outcome after radical prostatectomy in patients with low-grade prostate cancer | Q28709995 | ||
WNT signalling pathways as therapeutic targets in cancer | Q29615666 | ||
Integrative genomic profiling of human prostate cancer | Q29619905 | ||
Integrative molecular concept modeling of prostate cancer progression. | Q33266777 | ||
Estimation of metabolite concentrations from localized in vivo proton NMR spectra | Q72319396 | ||
Proton MR spectroscopy of prostatic tissue focused on the detection of spermine, a possible biomarker of malignant behavior in prostate cancer | Q73937761 | ||
Molecular sampling of prostate cancer: a dilemma for predicting disease progression | Q33541296 | ||
In silico estimates of tissue components in surgical samples based on expression profiling data | Q33642598 | ||
Challenging role of Wnt5a and its signaling pathway in cancer metastasis (Review). | Q33769672 | ||
Wnt signaling in cancer | Q34262857 | ||
Epithelial-mesenchymal transition in human cancer: comprehensive reprogramming of metabolism, epigenetics, and differentiation | Q34458518 | ||
Spermine and citrate as metabolic biomarkers for assessing prostate cancer aggressiveness | Q34693066 | ||
Gene signatures ESC, MYC and ERG-fusion are early markers of a potentially dangerous subtype of prostate cancer | Q35223291 | ||
Prostate cancer induces bone metastasis through Wnt-induced bone morphogenetic protein-dependent and independent mechanisms | Q35609965 | ||
Molecular classification of prostate cancer using curated expression signatures | Q35641563 | ||
A Balanced Tissue Composition Reveals New Metabolic and Gene Expression Markers in Prostate Cancer | Q35996026 | ||
Wnt signalling and prostate cancer | Q36089054 | ||
Roles and regulation of Wnt signaling and beta-catenin in prostate cancer | Q36197343 | ||
Suppression of Wnt/beta-catenin signaling inhibits prostate cancer cell proliferation | Q37086749 | ||
Discovery and characterization of a small molecule inhibitor of the PDZ domain of dishevelled. | Q37269189 | ||
The opposing roles of Wnt-5a in cancer | Q37551599 | ||
Prostate cancer bone metastases acquire resistance to androgen deprivation via WNT5A-mediated BMP-6 induction | Q37650625 | ||
Interplay of cadherin-mediated cell adhesion and canonical Wnt signaling | Q37698281 | ||
Wnt signalling and the control of cellular metabolism. | Q37708317 | ||
WNT signaling: an emerging mediator of cancer cell metabolism? | Q38263093 | ||
Role of epithelial mesenchymal transition in prostate tumorigenesis | Q38288544 | ||
Up-regulation of Wnt-1 and beta-catenin production in patients with advanced metastatic prostate carcinoma: potential pathogenetic and prognostic implications. | Q38446601 | ||
WNT5A-mediated β-catenin-independent signalling is a novel regulator of cancer cell metabolism | Q38628775 | ||
WNT5A has anti-prostate cancer effects in vitro and reduces tumor growth in the skeleton in vivo | Q38956252 | ||
Regulation of prostate cancer cell migration toward bone marrow stromal cell-conditioned medium by Wnt5a signaling | Q39092267 | ||
Polyamines modulate epithelial-to-mesenchymal transition | Q39477470 | ||
Wnt5a signaling is involved in the aggressiveness of prostate cancer and expression of metalloproteinase | Q39747925 | ||
Wnt3a growth factor induces androgen receptor-mediated transcription and enhances cell growth in human prostate cancer cells. | Q40479983 | ||
Activation of β-catenin signaling in androgen receptor-negative prostate cancer cells | Q40834731 | ||
A switch from E-cadherin to N-cadherin expression indicates epithelial to mesenchymal transition and is of strong and independent importance for the progress of prostate cancer | Q42522113 | ||
WNT signaling regulates self-renewal and differentiation of prostate cancer cells with stem cell characteristics | Q46051855 | ||
Spatially matched in vivo and ex vivo MR metabolic profiles of prostate cancer -- investigation of a correlation with Gleason score | Q46956034 | ||
Changes in gene transcription underlying the aberrant citrate and choline metabolism in human prostate cancer samples | Q47892665 | ||
Prostate tissue composition and MR measurements: investigating the relationships between ADC, T2, K(trans), v(e), and corresponding histologic features | Q48561667 | ||
A new method to provide a fresh frozen prostate slice suitable for gene expression study and MR spectroscopy | Q57185246 | ||
P433 | issue | 6 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | prostate cancer | Q181257 |
P304 | page(s) | 9572-9586 | |
P577 | publication date | 2016-12-24 | |
P1433 | published in | Oncotarget | Q1573155 |
P1476 | title | A novel non-canonical Wnt signature for prostate cancer aggressiveness | |
P478 | volume | 8 |
Q90146243 | Abi1 loss drives prostate tumorigenesis through activation of EMT and non-canonical WNT signaling |
Q100490624 | Emerging role of tumor cell plasticity in modifying therapeutic response |
Q98154696 | Epigenetic analysis identifies factors driving racial disparity in prostate cancer |
Q50260314 | Ex vivo metabolic fingerprinting identifies biomarkers predictive of prostate cancer recurrence following radical prostatectomy |
Q87828465 | Ex vivo metabolic fingerprinting identifies biomarkers predictive of prostate cancer recurrence following radical prostatectomy |
Q93200972 | Exploring the transcriptome of hormone-naive multifocal prostate cancer and matched lymph node metastases |
Q90599306 | FZD2 regulates cell proliferation and invasion in tongue squamous cell carcinoma |
Q61796260 | Loss of MADD expression inhibits cellular growth and metastasis in anaplastic thyroid cancer |
Q64230297 | Metabolomics Biomarkers of Prostate Cancer: A Systematic Review |
Q62555115 | Polyamine metabolism and cancer: treatments, challenges and opportunities |
Q64114067 | RSPO3 is a prognostic biomarker and mediator of invasiveness in prostate cancer |
Q45723424 | SFRP4 gene expression is increased in aggressive prostate cancer |
Q47112301 | The Role and Mechanism of Epithelial-to-Mesenchymal Transition in Prostate Cancer Progression |
Q41491922 | Treatment with the WNT5A-mimicking peptide Foxy-5 effectively reduces the metastatic spread of WNT5A-low prostate cancer cells in an orthotopic mouse model. |
Q47818549 | WNT signalling in prostate cancer. |
Q49578198 | WNT5A induces castration-resistant prostate cancer via CCL2 and tumour-infiltrating macrophages |
Q90687151 | Wnt Signaling Drives Prostate Cancer Bone Metastatic Tropism and Invasion |
Q92783226 | Wnt Signaling Pathways in Keratinocyte Carcinomas |
Search more.